A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...
Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study This randomized, parallel-group, phase II study ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...
The Well News on MSN
Clinical trial tested high-dose vitamin D for COVID with mixed results
WASHINGTON - Long COVID remains one of the more stubborn medical puzzles of the past several years. Millions of people who ...
Patient enrollment accelerates across expanding number of clinical trial sites in multiple countries 8 patients enrolled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results